{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-071011","form_type":"8-K","ticker":"EWTX","cik":"0001710072","company_name":"Edgewise Therapeutics, Inc.","filed_at":"2026-06-05T20:33:33+00:00","discovered_at":"2026-06-05T20:34:00.415607+00:00","generated_at":"2026-06-05T20:35:29.612709+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Edgewise Therapeutics stockholders elect three directors, ratify auditor, approve say-on-pay at 2026 annual meeting","bullets":["Laura Brege (87.3M for), Badreddin Edris (64.1M for), Jonathan Root (59.2M for) elected Class II directors.","KPMG LLP ratified as independent auditor for FY2026 with 99.6M for, 1.1K against, 578K abstain.","Say-on-pay advisory vote approved: 87.1M for, 3.5M against, 577K abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-071011","json":"https://secwatch.observer/filing/0001104659-26-071011.json","markdown":"https://secwatch.observer/filing/0001104659-26-071011.md","text":"https://secwatch.observer/filing/0001104659-26-071011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/tm2616953d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T20:35:29.612709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25e65d1dfd7b76f673dbb711cb76b46f65166009","claim":"Edgewise Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 99,637,228 1,123 578,031","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"76d7d36f3c0391db9f140ee5e5b7e67dc9bdef10","claim":"Edgewise Therapeutics, Inc. shareholders approved Election of three Class II Directors at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 1: Election of three Class II Directors Name of Director For Withheld Laura Brege 87,300,827 3,822,867 Badreddin Edris, Ph.D. 64,082,681 27,041,013 Jonathan Root, M.D. 59,213,781 31,909,913","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"77137fcb65e37fe5b31f10467ba8af5fdef95981","claim":"Edgewise Therapeutics, Inc. shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 3: Advisory Vote on the Compensation of the Company's Named Executive Officers For Against Abstain 87,055,111 3,491,326 577,257","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}